Navigation Links
Lilly Reports Third-Quarter 2011 Results
Date:10/20/2011

nder)20112010

2010

2011

2010

2010Zyprexa®

$1,182.3$1,212.7(3)%$3,872.4$3,690.65%Cymbalta®

1,068.6825.329%2,980.82,496.219%Alimta

629.7560.312%1,823.01,639.511%Humalog®

593.2494.020%1,705.51,505.113%Cialis

469.8406.516%1,381.41,233.512%Humulin®

301.5278.08%903.2801.013%Evista®

270.1256.85%799.7757.96%Forteo®

240.3199.720%687.3603.814%Strattera

153.2127.920%449.5421.37%Gemzar

91.0324.6(72)%359.5905.8(60)%Animal Health

451.0353.228%1,210.4967.025%Total Revenue

$6,147.9$5,654.89%$18,239.9$16,889.08%Zyprexa

In the third quarter of 2011, Zyprexa sales totaled $1.182 billion, a decrease of 3 percent compared with the third quarter of 2010.  U.S. sales of Zyprexa decreased 7 percent to $563.2 million, driven by lower volume, partially offset by higher net effective selling prices. Zyprexa sales in international markets increased 2 percent, to $619.1 million, driven primarily by the favorable impact of foreign exchange rates, partially offset by lower prices and lower volume. The company lost patent exclusivity for Zyprexa in most of Europe in September 2011 and will lose exclusivity in the U.S. on October 23, 2011. While it is difficult to predict the precise timing and magnitude of the impact on Zyprexa sales, the company expects the introduction of generics to result in a rapid and severe decline in Zyprexa sales.  

Cymbalta

For the third quarter of 2011, Cymbalta generated $1.069 billion in revenue, an increase of 29 percent compared with the third quarter of 2010. U.S. sales of Cymbalta increased 26 percent, to $809.5 million, driven by increased prices and higher demand. Revenue outside the U.S. was $259.1 million, an increase of 42 percent, driven primarily by higher demand in international markets and, to a lesser extent, the favorable impact of foreign exchange rates.

Alimta

For the
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Lilly Declares Fourth-Quarter 2011 Dividend
2. Lilly Announces Changes in Senior Management
3. Lilly Confirms Date and Conference Call for Third-Quarter 2011 Financial Results Announcement
4. Lilly Improves Its Environmental Footprint in Business Operations and Helps Beautify Communities
5. Eli Lilly and Company Bringing Diabetes Education Program to the Annual Legislative Conference
6. Lilly Celebrates 17th Consecutive Year as One of Working Mother 100 Best Companies
7. Lilly Health Channel Debuts on YouTube
8. Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes
9. The American Diabetes Association and Eli Lilly and Company Encourage African Americans to Learn About Diabetes Through a Familiar Face
10. Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
11. U.S. Court of Appeals Affirms Validity of Lillys Strattera Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... YORK, Pa. , July 1, 2015  Unilife ... developer, manufacturer and supplier of injectable drug delivery systems, ... been amended as of June 30, 2015. This amendment ... least $20 million in cash receipts from customers during ... no other adjustments to any of the terms of ...
(Date:7/1/2015)... Qiming Venture Partners, today announces the promotion ... immediately. William has been with Qiming for ... many Qiming healthcare deals, and assisted many of these ... s success in healthcare is not a small part ... his outstanding advocacy and service mentality on behalf of ...
(Date:7/1/2015)... -- According to a new market research ... (Calcium Phosphate, Lipofection, Dendrimers), Physical (Electroporation, Nucleofection), Viral), by ... to 2020", published by MarketsandMarkets, the Transfection Reagents and ... by 2020 with a CAGR of 7.2% from 2014 ... ables and 33 F igures ...
Breaking Medicine Technology:Unilife and OrbiMed Amend Debt Financing Agreement 2Unilife and OrbiMed Amend Debt Financing Agreement 3Qiming Announces the Promotion of William Hu to Managing Partner 2Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 2Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 3Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 4
... Oct. 5 Alma Lasers, a global developer, ... ultrasound devices for aesthetic and medical applications announced ... supporters committed to fighting breast cancer through awareness, ... Awareness and the newly launched SopranoXLi Pain-Free Hair-Free ...
... Oct. 5 According to Millennium Research Group (MRG), ... Canadian interventional cardiology device market is a highly competitive ... competitors fighting for market share in this extremely profitable ... a $55 million market -- the most lucrative of ...
Cached Medicine Technology:Alma Lasers Joins the Fight Against Breast Cancer with the Launch of the NEW SopranoXLi 2Canadian Health Care System Pressuring Manufacturers to Lower Drug-Eluting Stent Prices in US$55 Million Market 2Canadian Health Care System Pressuring Manufacturers to Lower Drug-Eluting Stent Prices in US$55 Million Market 3
(Date:7/2/2015)... CA (PRWEB) , ... July 02, 2015 , ... ... mission driven Nutraceutical company, is announcing with their launch an intention to partner ... safe holistic health solutions on the planet. Their innovative water soluble, Cannabidiol (CBD) ...
(Date:7/2/2015)... Beach, FL (PRWEB) , ... July 02, 2015 , ... ... information and entertainment differently, but also how they interact with products in their everyday ... everything from appliances and security systems to home entertainment and safety, as well as ...
(Date:7/2/2015)... ... ... can have an effect on the body. And during the hot summer season, fitness guru ... eating enough of the right foods, as well as drinking plenty of water. , But ... the food front as well, with sweet treats like ice cream and snow cones more popular ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... the California Department of State Hospitals. Prior to using Winscribe’s dictation and clinical ... telephone dictation system to manage their organization’s dictation and transcription processes. ...
(Date:7/2/2015)... ... July 02, 2015 , ... Maddock ... services, channels and business models. To help manage the increasing demand for innovation ... Mark Benkendorf as SVP of Strategic Engagements. , Benkendorf is a seasoned management ...
Breaking Medicine News(10 mins):Health News:New Water Soluble CBD Provides Manufacturers & Distributors a More Effective, Safe, & Cost Efficient Alternative to Traditional CBD Oil 2Health News:New Water Soluble CBD Provides Manufacturers & Distributors a More Effective, Safe, & Cost Efficient Alternative to Traditional CBD Oil 3Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 2Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 3Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 4Health News:Iryna Lobur Shares Healthy Treats to Eat for Summer 2Health News:Patton State Hospital Saves Over 50% and Removes Document Backlogs with Winscribe Text 2Health News:Patton State Hospital Saves Over 50% and Removes Document Backlogs with Winscribe Text 3Health News:Patton State Hospital Saves Over 50% and Removes Document Backlogs with Winscribe Text 4Health News:Business Builder Mark Benkendorf Joins Innovation Firm Maddock Douglas 2
... from Princess Margaret Hospital (PMH) are using a new ... therapy , takes less than an hour and eliminates ... PMH team combined the expertise of surgeons, radiation medicine ... perform its first procedure. It marked the first time ...
... According to a study published online ahead of print in ... coffee are less likely to develop an involuntary eye spasm ... uncontrollably and can leave them effectively blind. ,The ... one to two cups per day were needed for the ...
... Wang and colleagues identify the key signaling molecules that ... niche, using a combination of mouse mutant analyses , ... have a limited capacity to regenerate teeth, mouse incisors ... ,The researchers show that signals from the adjacent ...
... June 20 (IANS) While the Nepalese government's attention is ... Syndrome (AIDS) among migrant labourers, intravenous drug users ... most vulnerable groups in the country with the rate ... ,According to Nepal's National Centre for AIDS and ...
... The State Department is conducting an internal survey to better ... like Iraq and Afghanistan , a Department official said in ... the head of the State Department's Office of Medical Services, ... the anonymous survey on the Department's intranet system on June ...
... may be unaware they carry a genetic risk of breast ... on current genetic testing guidelines . ,Genetic ... in women with fewer than two female relatives who lived ... the family, according to researchers in California. ...
Cached Medicine News:Health News:Interoperative Radiotherapy for Breast Cancer Patients 2Health News:Eyelid Spasm can Be Prevented by Coffee Drinking 2Health News:Huge Rise in AIDS Cases Among Nepal Housewives 2Health News:US Concerned About Mental Health of Diplomats in Iraq, Afghanistan 2
S-ROM acetabular cups provide a variety of geometrical options to help address many anatomical situations and defects....
S-ROM acetabular cups provide a variety of geometrical options to help address many anatomical situations and defects....
The Trident PSL Acetabular Shells are designed to maximize fixation in the peripheral lunate region of the acetabulum....
The Trident ceramic acetabular system provides several important benefits and meets greater demands of younger, more active patients....
Medicine Products: